FIGS (NYSE:FIGS) Stock Price Up 6.8%

FIGS, Inc. (NYSE:FIGS) was up 6.8% during mid-day trading on Thursday . The company traded as high as $5.33 and last traded at $5.32. Approximately 2,081,070 shares traded hands during trading, a decline of 45% from the average daily volume of 3,785,605 shares. The stock had previously closed at $4.98.

Analyst Upgrades and Downgrades

FIGS has been the topic of a number of recent research reports. Roth Mkm dropped their target price on FIGS from $7.50 to $6.75 and set a “buy” rating on the stock in a report on Friday, May 10th. Telsey Advisory Group restated a “market perform” rating and issued a $6.00 target price on shares of FIGS in a research note on Monday, August 5th. Finally, The Goldman Sachs Group increased their price target on shares of FIGS from $4.25 to $4.75 and gave the stock a “sell” rating in a report on Friday, August 9th. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.40.

FIGS Price Performance

The firm has a market capitalization of $919.23 million, a PE ratio of 48.00, a P/E/G ratio of 86.00 and a beta of 1.42. The company has a 50-day moving average price of $5.55 and a 200-day moving average price of $5.43.

FIGS (NYSE:FIGS) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.01 earnings per share for the quarter. FIGS had a net margin of 4.07% and a return on equity of 6.12%. The business had revenue of $144.23 million during the quarter, compared to analyst estimates of $142.25 million. During the same quarter in the previous year, the business posted $0.02 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis. On average, research analysts predict that FIGS, Inc. will post 0.03 earnings per share for the current fiscal year.

Insider Activity

In other FIGS news, insider Heather L. Hasson sold 40,149 shares of FIGS stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $5.70, for a total value of $228,849.30. Following the completion of the sale, the insider now owns 425,710 shares in the company, valued at approximately $2,426,547. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 44,638 shares of company stock valued at $252,720 over the last quarter. Company insiders own 22.30% of the company’s stock.

Institutional Investors Weigh In On FIGS

Institutional investors have recently added to or reduced their stakes in the company. Eagle Asset Management Inc. acquired a new position in shares of FIGS during the fourth quarter worth about $12,152,000. Wellington Management Group LLP boosted its holdings in shares of FIGS by 321.5% in the 4th quarter. Wellington Management Group LLP now owns 3,075,794 shares of the company’s stock valued at $21,377,000 after buying an additional 2,345,994 shares during the period. ProShare Advisors LLC raised its stake in FIGS by 26.6% during the first quarter. ProShare Advisors LLC now owns 766,465 shares of the company’s stock worth $3,817,000 after acquiring an additional 161,249 shares during the period. Applied Fundamental Research LLC lifted its holdings in FIGS by 25.8% in the first quarter. Applied Fundamental Research LLC now owns 2,495,381 shares of the company’s stock worth $12,427,000 after acquiring an additional 511,794 shares during the last quarter. Finally, Oppenheimer & Co. Inc. boosted its stake in FIGS by 499.6% in the fourth quarter. Oppenheimer & Co. Inc. now owns 214,589 shares of the company’s stock valued at $1,491,000 after acquiring an additional 178,800 shares during the period. Hedge funds and other institutional investors own 92.21% of the company’s stock.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.